RS20050731A - Kompozicije koje obuhvataju imunomodulatore ili imunosupresore t-ćelija u kombinaciji sa antibakterijskim sredstvima - Google Patents

Kompozicije koje obuhvataju imunomodulatore ili imunosupresore t-ćelija u kombinaciji sa antibakterijskim sredstvima

Info

Publication number
RS20050731A
RS20050731A YUP-2005/0731A YUP20050731A RS20050731A RS 20050731 A RS20050731 A RS 20050731A YU P20050731 A YUP20050731 A YU P20050731A RS 20050731 A RS20050731 A RS 20050731A
Authority
RS
Serbia
Prior art keywords
bacterial
macrolide
combination
antibacterial agent
immunomodulator
Prior art date
Application number
YUP-2005/0731A
Other languages
English (en)
Serbian (sr)
Inventor
Maximilian Grassberger
Johannes Hildebrandt
Stefan Hirsch
Carle Paul
Neil Stewart Ryder
Nabila Sekkat
Anton Stutz
Original Assignee
Novartis Ag.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag., filed Critical Novartis Ag.,
Publication of RS20050731A publication Critical patent/RS20050731A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YUP-2005/0731A 2003-04-04 2004-04-02 Kompozicije koje obuhvataju imunomodulatore ili imunosupresore t-ćelija u kombinaciji sa antibakterijskim sredstvima RS20050731A (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307862.3A GB0307862D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003510 WO2004087143A1 (en) 2003-04-04 2004-04-02 Compositions comprising macrolide t-cell immunomodulators or immunosuppressants in combination with antibacterials

Publications (1)

Publication Number Publication Date
RS20050731A true RS20050731A (sr) 2007-11-15

Family

ID=9956225

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0731A RS20050731A (sr) 2003-04-04 2004-04-02 Kompozicije koje obuhvataju imunomodulatore ili imunosupresore t-ćelija u kombinaciji sa antibakterijskim sredstvima

Country Status (13)

Country Link
US (1) US20070117764A1 (https=)
EP (1) EP1613316A1 (https=)
JP (1) JP2006522056A (https=)
CN (1) CN1771035A (https=)
AU (1) AU2004226818A1 (https=)
BR (1) BRPI0409190A (https=)
CA (1) CA2521260A1 (https=)
GB (1) GB0307862D0 (https=)
IS (1) IS8104A (https=)
MX (1) MXPA05010700A (https=)
NO (1) NO20055180L (https=)
RS (1) RS20050731A (https=)
WO (1) WO2004087143A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307864D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
CN101711869B (zh) * 2009-09-23 2012-04-04 王国礼 喹诺酮类抗菌药物在银屑病治疗中的应用
JP7446594B2 (ja) * 2017-07-21 2024-03-11 学校法人東京薬科大学 好中球細胞外トラップ形成促進剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0209474A (pt) * 2001-05-09 2006-02-07 Novartis Ag Métodos para imunomodulação seletiva
US20030021816A1 (en) * 2001-06-06 2003-01-30 Sewon Kang Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
WO2003004098A1 (en) * 2001-07-06 2003-01-16 Sucampo Ag Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
US20030207819A1 (en) * 2002-05-02 2003-11-06 Moskowitz Roland W. Compositions and methods for treating inflammatory connective tissue diseases

Also Published As

Publication number Publication date
US20070117764A1 (en) 2007-05-24
NO20055180L (no) 2006-01-04
WO2004087143A1 (en) 2004-10-14
JP2006522056A (ja) 2006-09-28
BRPI0409190A (pt) 2006-04-11
GB0307862D0 (en) 2003-05-14
IS8104A (is) 2005-10-31
CA2521260A1 (en) 2004-10-14
NO20055180D0 (no) 2005-11-03
CN1771035A (zh) 2006-05-10
MXPA05010700A (es) 2005-12-12
AU2004226818A1 (en) 2004-10-14
EP1613316A1 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
CA2399971C (en) Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
RS20050739A (sr) Farmaceutska kompozicija koja obuhvata imunosupresant za upotrebu u lečenju oboljenja kože
RS20050731A (sr) Kompozicije koje obuhvataju imunomodulatore ili imunosupresore t-ćelija u kombinaciji sa antibakterijskim sredstvima
CN100475199C (zh) 大环内酯t-细胞调节剂或免疫抑制剂与类视色素的协同组合
AU2004226820B2 (en) Combination of a macrolide T-cell immunomodulator and a calciferol for the treatment of skin diseases or of inflammatory bowel disease
RS20050723A (sr) Organska jedinjenja
RS20050752A (sr) Kombinacija makrolida i lokalnog anestetika za tretman dermatoloških oboljenja
AU2004226822B2 (en) Pharmaceutical composition comprising a macrolide immunomodulator